检索结果 - Ray D. Page

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Opioids and Cancer Pain: Patients’ Needs and Access Challenges

    Opioids and Cancer Pain: Patients’ Needs and Access Challenges 由 Ray D. Page, Elizabeth Blanchard

    出版 2019
    获取全文 获取全文
    Editorial
    加到收藏夹
    Saved in:
  2. 2
    Primary hepatic lymphoma

    Primary hepatic lymphoma 由 Ray D. Page, Jorge Romaguera, Barbara M. Osborne, L. Jeffrey Medeiros, José Rodríguez, L North, César Sanz-Rodrı́guez, Fernando Cabanillas

    出版 2001
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer

    Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer 由 Mark A. Socinski, Corey J. Langer, Isamu Okamoto, Jeremy K. Hon, Vera Hirsh, Shaker R. Dakhil, Ray D. Page, James Orsini, H. Zhang, Markus F. Renschler

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Multicenter Phase II Trial of ABI-007, an Albumin-Bound Paclitaxel, in Women With Metastatic Breast Cancer

    Multicenter Phase II Trial of ABI-007, an Albumin-Bound Paclitaxel, in Women With Metastatic Breast Cancer 由 Nuhad K. Ibrahim, Brian L. Samuels, Ray D. Page, Dinesh Chandra Doval, Kirtikumar M. Patel, Sujaya Rao, Madhavan Krishnan Nair, Paul Bhar, Neil Desai, Gabriel N. Hortobágyi

    出版 2005
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer

    Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer 由 Natasha B. Leighl, Ray D. Page, Victoria M. Raymond, Davey B. Daniel, Stephen G. Divers, Karen L. Reckamp, Miguel A. Villalona‐Calero, Daniel Dix, Justin I. Odegaard, Richard B. Lanman, Vassiliki A. Papadimitrakopoulou

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Telehealth in Oncology: ASCO Standards and Practice Recommendations

    Telehealth in Oncology: ASCO Standards and Practice Recommendations 由 Robin Zoň, Erin B. Kennedy, Kerin B. Adelson, Sibel Blau, N Dickson, David Gill, Nicole Laferriere, Ana María López, Therese M. Mulvey, Debra A. Patt, Todd Pickard, Terry Purdom, Trevor J. Royce, Ashley Sumrall, Ray D. Page

    出版 2021
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  7. 7
    P3.02c-026 Is Nivolumab Safe and Effective in Elderly and PS2 Patients with Non-Small Cell Lung Cancer (NSCLC)? Results of CheckMate 153

    P3.02c-026 Is Nivolumab Safe and Effective in Elderly and PS2 Patients with Non-Small Cell Lung Cancer (NSCLC)? Results of CheckMate 153 由 David R. Spigel, Lee S. Schwartzberg, David Waterhouse, Jason C. Chandler, Maen Hussein, Robert M. Jotte, Edward J. Stepanski, Michael McCleod, Ray D. Page, Rohini Sen, Jeffrey G. McDonald, Kelly L. Bennett, Beata Korytowsky, Nivedita Aanur, Craig H. Reynolds

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

    Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC 由 Jennifer J. Knox, Carlos H. Barrios, T.M. Kim, Thomas M. Cosgriff, Vichien Srimuninnimit, K. Pittman, Roberto Sabbatini, Sun Young Rha, Thomas W. Flaig, Ray D. Page, J. Thaddeus Beck, Florence Cheung, S. Yadav, Poulam M. Patel, Lionnel Geoffrois, Julie Niolat, Noah Berkowitz, Mahtab Marker, Dehui Chen, Robert J. Motzer

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma

    Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Re... 由 Robert J. Motzer, Carlos H. Barrios, Tae Min Kim, S. Falcon, Thomas M. Cosgriff, W G Harker, Vichien Srimuninnimit, Ken Pittman, Roberto Sabbatini, Sun Young Rha, Thomas W. Flaig, Ray D. Page, Sevil Bavbek, J. Thaddeus Beck, Poulam M. Patel, F.Y. Cheung, Sunil Kumar Yadav, Edward Schiff, Xufang Wang, Julie Niolat, Dalila Sellami, Oezlem Anak, Jennifer J. Knox

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer

    PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer 由 Hui Yu, Cory Batenchuk, A. Badzio, Theresa A. Boyle, Piotr Czapiewski, Daniel C. Chan, Xian Lu, Dexiang Gao, Kim Ellison, Ashley Kowalewski, Christopher J. Rivard, Rafał Dziadziuszko, Caicun Zhou, Maen Hussein, Donald Richards, Sharon Wilks, Marc Monte, William J. Edenfield, Jerome H. Goldschmidt, Ray D. Page, Brian Ulrich, David Waterhouse, Sandra Close, Jacek Jassem, Kimary Kulig, Fred R. Hirsch

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: